Bizzari Jean-pierre is a director of Aprea Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ADC Therapeutics SA
18 Jun 24
144
ADC Therapeutics SA
18 Jun 24
4
ADC Therapeutics SA
14 Jun 24
3
ADC Therapeutics SA
2 Jan 24
4
Aprea Therapeutics, Inc.
24 Aug 23
3
Aprea Therapeutics, Inc.
24 Aug 23
4
HALOZYME THERAPEUTICS, INC.
9 May 23
4
HALOZYME THERAPEUTICS, INC.
6 May 22
4
HALOZYME THERAPEUTICS, INC.
25 Aug 21
4
HALOZYME THERAPEUTICS, INC.
6 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jun 24 | ADCT ADC Therapeutics | Common Shares | Sell | Dispose S | No | No | 2.89 | 6,995 | 20.22 k | 79,502 |
13 Jun 24 | ADCT ADC Therapeutics | Common Shares | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 86,497 |
23 Aug 23 | APRE Aprea Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 3.65 | 12,500 | 45.63 k | 12,500 |